A session at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition highlights menstrual disorders in adolescent girls.
Much like a person’s pulse rate, body temperature, respiration rate and blood pressure, menstruation can serve as a vital sign of a girl’s health and menstrual issues can indicate underlying health concerns. At the virtual 2021 American Academy of Pediatrics National Conference & Exhibition, Selma F. Witchel, MD, FAAP, professor of pediatrics at UPMC Children’s Hospital of Pittsburgh in Pennsylvania discussed the difference between normal and abnormal menses, the available toolbox, common irregular menses situations, and what to consider with menses in special populations.
The median age at menarche is 12.43 years. Normal menarche has a flow length of ≤7 days and typical product use is 3 to 6 pads or tampons a day. The cycle interval is irregular during the first gynecologic year; 21-45 days during the second gynecologic year; and 21-35 days from third gynecologic year until menopause. Signs of abnormal menses include menses lasting more than 7 days; initially regular menses becoming irregular; menses requiring pad/tampon changes every 1-2 hours and throughout the night; no menses by age 15 years with appropriate pubertal development; and no menses within 3 years of the onset of breast development.
Therapies available in the toolbox to use with menstrual disorders include combined oral contraceptives, the vaginal ring, depot medroxyprogesterone acetate, progestin-containing intrauterine devices, gonadotropin-releasing hormone (GnRH)-superagonists, and etronogestrel subnormal implants. Witchel noted that providers should be aware of whether treatments could impact bone mineral density during such a pivotal time, like combined oral contraceptives that have a mild negative impact or depot medroxyprogesterone acetate that has a significant adverse effect, or carry a risk of venous thromboembolism, such as combined oral contraceptives.
Witchel then discussed common irregular menstrual concerns including:
The session ended with Witchel discussing menstruation in adolescent girls with disabilities. She noted that menstrual management or suppression is often desired by this group. Providers should engage in shared decision-making when possible. Some physical disabilities may make some forms of menstrual hygiene more difficult or undesirable. Some medications may cause hyperprolactinemia and interactions may occur between some seizure medications and sex steroids. A hysterectomy is not considered appropriate management in this group. If it’s being considered as a last resort, Witchel recommended a consult with an ethics committee.
Reference
1. Witchel S. Evaluation and management of menstrual disorders in teens. American Academy of Pediatrics 2021 National Conference & Exhibition; virtual. Accessed October 8, 2021.
Inactivated COVID-19 vaccines in pregnancy: No impact on neonatal outcome, study finds
November 28th 2023A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.
Read More
Late-preterm antenatal corticosteroid treatment in twin pregnancies and newborn morbidity
November 27th 2023A recent retrospective cohort study found that administering antenatal corticosteroids from 34 to 36 weeks of gestation did not decrease composite neonatal respiratory morbidity in twin pregnancies, challenging conventional practices for this high-risk population.
Read More
The impact of WIC enrollment on breastfeeding rates: A comprehensive study
November 21st 2023Explore the findings of a recent study, revealing that enrollment in the Special Supplemental Nutritional Program for Women, Infants, and Children may influence breastfeeding decisions, shedding light on disparities and suggesting the need for targeted initiatives to enhance breastfeeding rates among low-income mothers.
Read More